Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Cohen E"'
Autor:
Reid F; Clinical Development, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Singh D; Medicines Evaluation Unit, Manchester University NHS Foundation Trust, University of Manchester, Manchester, UK., Albayaty M; Parexel International, Early Phase Clinical Unit, Northwick Park Hospital, Harrow, UK., Moate R; Early Biostatistics and Statistical Innovation, Data Science and AI, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Jimenez E; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Barcelona, Spain., Sadiq MW; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Howe D; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Gavala M; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Killick H; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Williams A; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Krishnan S; GxP Testing Lab, Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA., Godwood A; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Shukla A; GxP Testing Lab, Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA., Hewitt L; GxP Testing Lab, Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA., Lei A; Patient Safety BioPharma, Chief Medical Office, R&D, AstraZeneca, Barcelona, Spain., Kell C; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Pandya H; Clinical Development, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Newcombe P; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., White N; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Scott IC; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Cohen ES; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Mar; Vol. 115 (3), pp. 565-575. Date of Electronic Publication: 2024 Jan 24.
Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE/EGFR signalling complex.
Autor:
Strickson S; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; These authors contributed equally to this work., Houslay KF; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; These authors contributed equally to this work., Negri VA; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ohne Y; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Ottosson T; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Dodd RB; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Huntington CC; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Baker T; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Li J; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Stephenson KE; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., O'Connor AJ; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Sagawe JS; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Killick H; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Moore T; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Rees DG; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Koch S; Imaging & Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Sanden C; Experimental Medical Sciences, Lund University, Lund, Sweden.; Medetect AB, Lund, Sweden., Wang Y; Imaging & Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Gubbins E; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ghaedi M; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Kolbeck R; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Current: Spirovant Sciences, Philadelphia, PA, USA., Saumyaa S; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Erjefält JS; Experimental Medical Sciences, Lund University, Lund, Sweden.; Allergology and Respiratory Medicine, Lund University, Skåne University Hospital, Lund, Sweden., Sims GP; Bioscience Immunology, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Humbles AA; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Current: Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Scott IC; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Romero Ros X; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; These authors contributed equally to this work., Cohen ES; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK suzanne.cohen@astrazeneca.com.; These authors contributed equally to this work.
Publikováno v:
The European respiratory journal [Eur Respir J] 2023 Sep 28; Vol. 62 (3). Date of Electronic Publication: 2023 Sep 28 (Print Publication: 2023).
Autor:
Stephenson KE; Division of Respiratory Medicine, School of Medicine, University of Nottingham, Nottingham, UK. katherine.stephenson@astrazeneca.com.; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. katherine.stephenson@astrazeneca.com., Porte J; Division of Respiratory Medicine, School of Medicine, University of Nottingham, Nottingham, UK., Kelly A; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Wallace WA; Division of Pathology, University of Edinburgh, Edinburgh, UK., Huntington CE; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Overed-Sayer CL; Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Cohen ES; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Jenkins RG; National Heart and Lung Institute, Imperial College London, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, Imperial College London, London, UK.; Interstitial lung disease unit, Royal Brompton Hospital, London, UK., John AE; Division of Respiratory Medicine, School of Medicine, University of Nottingham, Nottingham, UK.; National Heart and Lung Institute, Imperial College London, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, Imperial College London, London, UK.
Publikováno v:
Respiratory research [Respir Res] 2023 Mar 23; Vol. 24 (1), pp. 89. Date of Electronic Publication: 2023 Mar 23.
Autor:
Lu Y; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Basatemur G; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Scott IC; Translational Sciences and Experimental Medicine, Early Respiratory and Immunology, Biopharmaceuticals R&D, AstraZeneca, Cambridge, UK., Chiarugi D; The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK., Clement M; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Harrison J; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Jugdaohsingh R; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK., Yu X; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Newland SA; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Jolin HE; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Li X; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Chen X; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK; Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China., Szymanska M; Department of Pathology, Oslo University Hospital Rikshospitalet, Norway., Haraldsen G; Department of Pathology, Oslo University Hospital Rikshospitalet, Norway., Palmer G; Division of Rheumatology, Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva, Switzerland; Department of Pathology-Immunology, University of Geneva School of Medicine, Geneva, Switzerland., Fallon PG; School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland., Cohen ES; Bioscience Asthma, Early Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., McKenzie ANJ; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Mallat Z; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK; Institut National de la Santé et de la Recherche Médicale, Paris Cardiovascular Research Center, Paris, France. Electronic address: zm255@medschl.cam.ac.uk.
Publikováno v:
Immunity [Immunity] 2020 May 19; Vol. 52 (5), pp. 782-793.e5. Date of Electronic Publication: 2020 Apr 08.
Autor:
Vacca F; Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom., Chauché C; Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom., Jamwal A; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Hinchy EC; Bioscience Asthma, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Heieis G; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom., Webster H; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom., Ogunkanbi A; Division of Cell Signalling and Immunology, School of Life Sciences, Wellcome Trust Building, University of Dundee, Dundee, United Kingdom., Sekne Z; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Gregory WF; Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom.; Division of Microbiology & Parasitology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom., Wear M; The Edinburgh Protein Production Facility (EPPF), Wellcome Trust Centre for Cell Biology (WTCCB), University of Edinburgh, Edinburgh, United Kingdom., Perona-Wright G; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom., Higgins MK; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Nys JA; Bioscience Asthma, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Cohen ES; Bioscience Asthma, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., McSorley HJ; Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom.; Division of Cell Signalling and Immunology, School of Life Sciences, Wellcome Trust Building, University of Dundee, Dundee, United Kingdom.
Publikováno v:
ELife [Elife] 2020 May 18; Vol. 9. Date of Electronic Publication: 2020 May 18.
Autor:
Scott IC; Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Granta Park, Cambridge CB21 6GH, U.K. Scottia@medimmune.com., Rees DG; Department of Antibody Development and Protein Engineering, MedImmune, Granta Park, Cambridge CB21 6GH, U.K., Cohen ES; Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Granta Park, Cambridge CB21 6GH, U.K.
Publikováno v:
Biochemical Society transactions [Biochem Soc Trans] 2018 Oct 19; Vol. 46 (5), pp. 1345-1353. Date of Electronic Publication: 2018 Oct 08.
Autor:
Scott IC; Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Granta Park, Cambridge, CB21 6GH, United Kingdom. Scottia@medimmune.com., Majithiya JB; Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Granta Park, Cambridge, CB21 6GH, United Kingdom., Sanden C; Department of Experimental Medical Sciences, Lund University, Lund, Sweden., Thornton P; Neuroscience, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Granta Park, Cambridge, CB21 6GH, United Kingdom., Sanders PN; Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Granta Park, Cambridge, CB21 6GH, United Kingdom., Moore T; Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Granta Park, Cambridge, CB21 6GH, United Kingdom., Guscott M; Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Granta Park, Cambridge, CB21 6GH, United Kingdom., Corkill DJ; Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Granta Park, Cambridge, CB21 6GH, United Kingdom., Erjefält JS; Department of Experimental Medical Sciences, Lund University, Lund, Sweden., Cohen ES; Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Granta Park, Cambridge, CB21 6GH, United Kingdom.
Publikováno v:
Scientific reports [Sci Rep] 2018 Feb 20; Vol. 8 (1), pp. 3363. Date of Electronic Publication: 2018 Feb 20.
Autor:
Osbourn M; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK., Soares DC; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK., Vacca F; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK., Cohen ES; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Cambridge CB21 6GH, UK., Scott IC; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Cambridge CB21 6GH, UK., Gregory WF; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK., Smyth DJ; Institute of Immunology and Infection Research, and Centre for Immunity, Infection and Evolution, School of Biological Sciences, Ashworth Laboratories, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK; Wellcome Centre for Molecular Parasitology, Institute for Infection, Immunity and Inflammation, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow G12 8TA, UK., Toivakka M; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK; Institute of Immunology and Infection Research, and Centre for Immunity, Infection and Evolution, School of Biological Sciences, Ashworth Laboratories, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK., Kemter AM; Institute of Immunology and Infection Research, and Centre for Immunity, Infection and Evolution, School of Biological Sciences, Ashworth Laboratories, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK; Wellcome Centre for Molecular Parasitology, Institute for Infection, Immunity and Inflammation, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow G12 8TA, UK., le Bihan T; SynthSys, The Kings Buildings, University of Edinburgh, Edinburgh EH9 3BF, UK., Wear M; The Edinburgh Protein Production Facility (EPPF), Wellcome Trust Centre for Cell Biology (WTCCB), University of Edinburgh, King's Buildings, Max Born Crescent, Mayfield Road, Edinburgh EH9 3BF, UK., Hoving D; Wellcome Centre for Molecular Parasitology, Institute for Infection, Immunity and Inflammation, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow G12 8TA, UK., Filbey KJ; Institute of Immunology and Infection Research, and Centre for Immunity, Infection and Evolution, School of Biological Sciences, Ashworth Laboratories, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK., Hewitson JP; Institute of Immunology and Infection Research, and Centre for Immunity, Infection and Evolution, School of Biological Sciences, Ashworth Laboratories, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK; Centre for Immunology and Infection, Department of Biology, University of York YO10 5DD, York, UK., Henderson H; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK., Gonzàlez-Cìscar A; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK; Institute of Immunology and Infection Research, and Centre for Immunity, Infection and Evolution, School of Biological Sciences, Ashworth Laboratories, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK., Errington C; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK., Vermeren S; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK., Astier AL; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK., Wallace WA; Department of Pathology, Laboratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK., Schwarze J; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK., Ivens AC; Institute of Immunology and Infection Research, and Centre for Immunity, Infection and Evolution, School of Biological Sciences, Ashworth Laboratories, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK., Maizels RM; Institute of Immunology and Infection Research, and Centre for Immunity, Infection and Evolution, School of Biological Sciences, Ashworth Laboratories, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK; Wellcome Centre for Molecular Parasitology, Institute for Infection, Immunity and Inflammation, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow G12 8TA, UK. Electronic address: rick.maizels@glasgow.ac.uk., McSorley HJ; MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK; Institute of Immunology and Infection Research, and Centre for Immunity, Infection and Evolution, School of Biological Sciences, Ashworth Laboratories, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK. Electronic address: henry.mcsorley@ed.ac.uk.
Publikováno v:
Immunity [Immunity] 2017 Oct 17; Vol. 47 (4), pp. 739-751.e5.
Autor:
Cohen ES; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Scott IC; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Majithiya JB; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Rapley L; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Kemp BP; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., England E; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Rees DG; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Overed-Sayer CL; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Woods J; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Bond NJ; Department of Biopharmaceutical Development, Analytical Biotechnology, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Veyssier CS; Department of Biopharmaceutical Development, Analytical Biotechnology, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Embrey KJ; Department of Discovery Sciences, Innovative Medicines, AstraZeneca, Mereside, Alderley Park, SK10 4TG, UK., Sims DA; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland 20878, USA., Snaith MR; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Vousden KA; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Strain MD; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Chan DT; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Carmen S; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Huntington CE; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Flavell L; Department of Discovery Sciences, Innovative Medicines, AstraZeneca, Mereside, Alderley Park, SK10 4TG, UK., Xu J; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Popovic B; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Brightling CE; Department of Infection, Immunity and Inflammation, Institute for Lung Health, Leicester LE3 9QP, UK; NIHR Respiratory Biomedical Research Unit, University Hospitals of Leicester, Leicester LE3 9QP, UK., Vaughan TJ; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Butler R; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Lowe DC; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Higazi DR; Department of Biopharmaceutical Development, Analytical Biotechnology, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Corkill DJ; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., May RD; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Sleeman MA; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Mustelin T; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland 20878, USA.
Publikováno v:
Nature communications [Nat Commun] 2015 Sep 14; Vol. 6, pp. 8327. Date of Electronic Publication: 2015 Sep 14.
Autor:
Kaur D; Institute for Lung Health, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK., Gomez E, Doe C, Berair R, Woodman L, Saunders R, Hollins F, Rose FR, Amrani Y, May R, Kearley J, Humbles A, Cohen ES, Brightling CE
Publikováno v:
Allergy [Allergy] 2015 May; Vol. 70 (5), pp. 556-67. Date of Electronic Publication: 2015 Mar 16.